Premium
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib
Author(s) -
Cheng Matthew P.,
Kusztos Amanda E.,
Gustine Joshua N.,
DrydenPeterson Scott L.,
Dubeau Toni E.,
Woolley Ann E.,
Hammond Sarah P.,
Baden Lindsey R.,
Treon Steven P.,
Castillo Jorge J.,
Issa Nicolas C.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15627
Subject(s) - ibrutinib , medicine , bruton's tyrosine kinase , mantle cell lymphoma , chronic lymphocytic leukemia , aspergillosis , neutropenia , lymphoma , oncology , immunology , leukemia , tyrosine kinase , chemotherapy , receptor